about
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanomaEffector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseSingle-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigensCarbon nanotubes as vaccine scaffoldsA Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs.Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.Fusogenics: a recombinant immunotoxin-based screening platform to select internalizing tumor-specific antibody fragments.Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunityTCR recognition of peptide/MHC class II complexes and superantigensOptimization of a self antigen for presentation of multiple epitopes in cancer immunityDevelopment of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resectionProspective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial.TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.Mechanisms of immunization against cancer using chimeric antigens.Tumor-Associated Glycans and Immune SurveillanceT Cells Integrate Local and Global Cues to Discriminate between Structurally Similar AntigensThe rationale for prophylactic cancer vaccines and need for a paradigm shift.Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityImmunostimulatory colloidal delivery systems for cancer vaccines.Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.Order, disorder, death: lessons from a superorganism.What is recent in pancreatic cancer immunotherapy?Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.Regulatory T cells in tumor immunity.TAA polyepitope DNA-based vaccines: a potential tool for cancer therapyBasic and translational applications of engineered MHC class I proteins.Potential targets for pancreatic cancer immunotherapeutics.Structural basis for self-recognition by autoimmune T-cell receptors.Functional polymorphism rs7072793 C > T affect individual susceptibility to breast cancer by modulating CD25 transcription activity.The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.Conceptual aspects of self and nonself discrimination.The antibody repertoire of colorectal cancer.Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
P2860
Q24684238-421FAE81-77ED-425B-A205-4BBBF71245F9Q26744527-270CFABB-CDC1-443B-B825-327289948639Q28390624-5D6D8335-49F7-4DFF-852F-7D7092129DDCQ28392532-4AE41DF2-F603-4FFE-9B6B-F7E1EB113D21Q33671350-1B9CC49E-765E-48B5-9320-2CB11FBD4C67Q33685307-29337995-B8BC-43E8-89BA-B0CDE616CC7BQ33698112-FD2C97A4-F41F-489E-A7C9-FD50A5A4649BQ33763294-F122CFA4-E3D6-4741-9AE3-4E1C487E6BF9Q33853435-EEDF4A4C-FC01-485E-A4EE-F31CE7C0CC16Q33903025-82F63863-50A5-4C6E-B6B9-DE11739FFA2EQ34096503-B6D0091D-D0E2-4BC0-B20D-4F29170485E8Q34171867-71AF7124-C83C-4CA7-842F-CCF8EB6E5FC1Q34537491-665436F3-C6C2-400C-BA85-D963334E0E01Q34625208-6455343B-33CA-4E25-A59A-E462A590CDA6Q35060987-35ED04F3-95E2-43F7-8A32-1953AA21404DQ35204618-797EBA2A-C308-449A-9A30-A866037C8B1DQ35442846-28671840-176E-4CB0-93A8-A20727BAB199Q35890610-27E10657-9602-4A3F-B60C-6B7CE49734CCQ35893938-FAF51112-24A6-4B89-B004-7DD739B76A14Q36423899-6A85B8E9-8424-4846-A708-3C058E5B3679Q36459336-26B81C84-5FDD-4AD8-A99D-6C7479A1FD6DQ36460849-1AE0FD59-DE90-4DAC-BE6E-6A9188A60A5CQ36484597-065A7D6A-6249-4C0A-8E9A-029E5626BB14Q36521595-733CC299-877D-470A-973E-8A423FC1378BQ36543791-9333991D-6810-4761-9EC4-B971B3734C20Q36665335-D8FFF5F9-2DBA-42E5-A884-EAB6FCCCE76BQ36976664-B08432C6-F949-453C-A78B-1D1CD911050AQ37066228-EB22CF34-9CBA-4083-945F-364304719F92Q37659113-BA58F6E7-0F5D-478C-93CA-91EC0F75FE45Q37762224-5D94185F-5E48-4A39-BACB-0D329309D698Q37771268-76F77B47-5F0B-46CA-B60C-BD6F61B32AD3Q37787436-37A7427B-1096-493A-9AD7-EA30FBC1509EQ37861220-7D13D361-9D89-4FAB-99BB-0422E003C5F7Q38050478-73A747E1-4384-4FF6-BF9C-CA6C2B52EE81Q39418553-6E8F80C9-547A-4AA4-B526-F0EF90EB4A58Q39665718-1CDCFF1F-FE65-41D0-B5A8-5D11E924A640Q39980848-9630196B-19A9-443F-878D-F97EAD0223F2Q42011891-AB973BDF-4B35-4D94-9F99-14F55E859F23Q42695851-8800795F-AF25-420E-A1AB-440EDBFDD696Q47325812-BA33E5C4-606B-4C3D-A4FE-C9D478C6A800
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immune recognition of self in immunity against cancer.
@ast
Immune recognition of self in immunity against cancer.
@en
type
label
Immune recognition of self in immunity against cancer.
@ast
Immune recognition of self in immunity against cancer.
@en
prefLabel
Immune recognition of self in immunity against cancer.
@ast
Immune recognition of self in immunity against cancer.
@en
P2860
P356
P1476
Immune recognition of self in immunity against cancer.
@en
P2093
Alan N Houghton
José A Guevara-Patiño
P2860
P304
P356
10.1172/JCI22685
P407
P577
2004-08-01T00:00:00Z